Biogen Inc.
Current role
BIIB
Nicole C. Murphy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicole C. Murphy
The proxy statement of Biogen Inc. reports total compensation of $7,575,505 for Nicole C. Murphy in fiscal 2025, including a base salary of $909,109. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biogen Inc. (BIIB)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biogen Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher A. Viehbacher CEO, Board Member
- Caroline D. Dorsa Chairman
- Michael R. McDonnell CFO
- Sean Godbout Chief Accounting Officer
- Christopher Viehbacher Board Member
- Eric K. Rowinsky Board Member
- Jesus B. Mantas Board Member
- Lloyd B. Minor, M.D. Board Member
- Lloyd Minor Board Member
- Menelas Pangalos Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $909,109 | $7,575,505 |
| 2024 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $764,567 | $5,740,359 |
| 2023 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $670,642 | $5,714,319 |
| 2022 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $592,218 | $4,929,712 |
Recent activity
No call appearances or filed executive changes recorded yet.